Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Renalytix (RNLXY)
OTHER OTC:RNLXY
RNLXY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $1.77
Previous CloseN/A
Volume36.17K
Average Volume (3M)42.29K
Market Cap
$48.21M
Enterprise ValueN/A
Total Cash (Recent Filing)82.00K
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.51
Shares Outstanding165,603,010
10 Day Avg. Volume53,048
30 Day Avg. Volume42,288
Standard Deviation0.48
R-Squared0.06
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Renalytix News
PremiumCompany Announcements
Renalytix to Revert to Foreign Private Issuer Status---
Ownership Overview
21.14% Insiders
0.03% Mutual Funds
0.02% Other Institutional Investors
78.84% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RNLXY FAQ
What was Renalytix’s price range in the past 12 months?
Renalytix lowest stock price was $0.12 and its highest was $1.77 in the past 12 months.
What is Renalytix’s market cap?
Renalytix’s market cap is $48.21M.
When is Renalytix’s upcoming earnings report date?
Renalytix’s upcoming earnings report date is Mar 27, 2025 which is in 32 days.
How were Renalytix’s earnings last quarter?
Currently, no data Available
Is Renalytix overvalued?
According to Wall Street analysts Renalytix’s price is currently Overvalued.
Does Renalytix pay dividends?
Renalytix does not currently pay dividends.
What is Renalytix’s EPS estimate?
Renalytix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Renalytix have?
Renalytix has 165,603,010 shares outstanding.
What happened to Renalytix’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Renalytix?
Among the largest hedge funds holding Renalytix’s share is Gilder Gagnon Howe & Co LLC.. It holds Renalytix’s shares valued at 0.
---
Company Description
Renalytix
Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
---
RNLXY Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering RNLXY
1 Year
1 Year Success Rate
1/17 ratings generated profit
1 Year Average Return
-62.75%
reiterated a buy rating 9 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 5.88% of your transactions generating a profit, with an average return of -62.75% per trade.
---